Sublingual immunotherapy: Efficacy - Methodology and outcome of clinical trials

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 61, Issue 81, 2006, Pages 24-28

  Malling, H J ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Clinical efficacy; Clinical trial; Quality criteria; Sublingual immunotherapy

Indexed keywords

ANTIALLERGIC AGENT; IMMUNOMODULATING AGENT; PLACEBO; ALLERGEN; ANTIHISTAMINIC AGENT;

ALLERGIC DISEASE; CLINICAL TRIAL; DRUG EFFICACY; HEALTH CARE QUALITY; HUMAN; IMMUNOTHERAPY; INTERMETHOD COMPARISON; MEDICAL RESEARCH; MEDLINE; METHODOLOGY; MORBIDITY; NONPARAMETRIC TEST; PARAMETRIC TEST; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT DURATION; TREATMENT WITHDRAWAL; ALLERGY; CLINICAL PRACTICE; CONFIDENCE INTERVAL; HEALTH SURVEY; MEDICAL LITERATURE; OUTCOME ASSESSMENT; QUALITATIVE ANALYSIS; RELIABILITY; RETROSPECTIVE STUDY; SCREENING; SUBLINGUAL IMMUNOTHERAPY; CONTROLLED CLINICAL TRIAL; DESENSITIZATION; EMERGENCY TREATMENT; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; CLINICAL TRIALS; DESENSITIZATION, IMMUNOLOGIC; EMERGENCY TREATMENT; HUMANS; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 33744758057     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01158.x     Document Type: Review

References (12)

1. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995 274: 1800 1804.
2. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998 53: 461 472.
3. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001 134: 657 662.
4. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995 311: 1145 1148.
5. Altman DG, Bland JM. How to randomise. BMJ 1999 319: 703 704.
6. Enas GG, Enas NH, Spradin CT, Wilson MG, Wiltse CG. Baseline comparability in clinical trials. Drug Inf J 1990 24: 541 548.
7. Treasure T, MacRae KD. Minimisation: the platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does. BMJ 1998 317: 362 363.
8. Frew AJ, White PJ, Smith HE. Sublingual immunotherapy. J Allergy Clin Immunol 1999 104: 267 270.
9. Malling HJ. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002 2: 523 531.
10. Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001 285: 2000 2003.
11. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003 111: 437 448.
12. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 60: 4 12.